Publication | Open Access

DHMEQ, a new NF-κB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells

Hematological MalignancyMedicineInduces ApoptosisApoptosisImmunologyImmune RegulationCell DeathImmune Checkpoint InhibitorPharmacotherapyNew Nf-κb InhibitorAnti-cancer AgentPharmacologyCell SignalingCancer Research